Trials / Recruiting
RecruitingNCT06935227
Steri-Strip Tape Use in Unilateral Ectropion Surgery
Postoperative Outcomes of Steri-Strip Surgical Tape Use in Unilateral Ectropion Surgery: A Parallel-Controlled Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- Sponsor
- Claudia Aristizábal · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Currently, the incidence of involutional and chronic eyelid disorders, such as ectropion, has been increasing, as human life expectancy has risen worldwide (more than 600 million people are aged ≥ 60 years). Ectropion is a common eyelid malposition that causes visual morbidity. It is characterized by eversion of the eyelid margin and has multiple etiologies. Steri-Strip tapes have been used in some ophthalmologic procedures, such as blepharoplasties, where they help prevent infections by acting as a barrier method, are resistant enough to reduce the risk of wound dehiscence, simplify postoperative care, and allow for proper eyelid fissure closure. Their use has been recommended in patients with facial paralysis to prevent keratitis or exposure ulcers. However, current evidence is limited, as their use has only been documented in case series and letters to the editor. Therefore, a randomized controlled clinical trial is proposed to evaluate the postoperative outcomes of Steri-Strip tape use in unilateral ectropion surgery compared to standard postoperative management.
Detailed description
This study will compare the use of Steri-Strip tape in unilateral ectropion surgery with standard postoperative care to assess cosmetic and functional outcomes in the adult population. Participants will be followed up at 8 and 30 days after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Use Steri-Strip in post-surgery + standard care | Steri-strip will be maintained for 8 days postoperatively. |
| OTHER | Standard care | Postoperative care recommendations. |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2025-04-20
- Last updated
- 2025-06-11
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT06935227. Inclusion in this directory is not an endorsement.